(Date:12/16/2009)... University (NTU) signed the Memorandum of Understanding in ... (CNRS) and the Thales Group of Companies to ... parties are meeting again in Singapore to inaugurate ... , Located at the Research Techno Plaza, ... in science and technology to develop innovations in ...
(Date:12/16/2009)... Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the life ... policy, to families nationwide and internationally, said today ... total of $1.4 million so far in the ... for the year now tops $10 million. ,, ...
(Date:12/16/2009)... Protocol Assessment with the Food and Drug ... - AEterna Zentaris Inc. (NASDAQ: AEZS ... biopharmaceutical company focused on oncology and endocrine ... partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), ... for perifosine (KRX-0401), the Company,s PI3K/Akt pathway ...
(Date:12/15/2009)... Calif., Dec. 15 Epeius Biotechnologies Corporation, ... genetic medicine, gained international validation of the cutting-edge ... , when scientists around the world rediscovered the ... major locus of cancer pathogenesis and disease progression, ... Recently, scientists at the NIH National Cancer Institute ...
Breaking Biology Technology:New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3(Date:12/16/2009)... national healthcare consulting firm, reported success this week ... the total amount of money that its hospital ... than a half-million patients nationwide by doing a ... in less than two years. ,, "We,re proud ... lines and still were able to significantly increase ...
(Date:12/16/2009)... SOMERVILLE, N.J., Dec. 16 Ethicon, Inc., ... ) company and a worldwide leader in surgical ... technology company dedicated to designing, developing and commercializing ... and throat (ENT), today announced a definitive merger ... all-cash transaction for approximately $785 million net of ...
(Date:12/16/2009)... Inc. (NYSE: HSP ), a leading global ... it will host a conference call to discuss its ... on Thursday, Feb. 4, 2010, at 8 a.m. Central ... full-year 2009 results earlier that morning, before the U.S. ... live webcast of the conference call will be available ...
Breaking Medicine Technology:Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 1Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 2Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 3New Anesthesia May Be Safer for Critically Ill 52600 1New Anesthesia May Be Safer for Critically Ill 52600 21 in 7 Low Income Preschoolers Is Obese 52597 11 in 7 Low Income Preschoolers Is Obese 52597 2